US Stock MarketDetailed Quotes
BRTH Breathe BioMedical
- 0.000
- 0.0000.00%
Close Nov 29 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)10.91MShares0.00052wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM2.63MShs Float0.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
About Breathe BioMedical Company
Breathe BioMedical Inc is developing a platform technology designed to detect diseases in exhaled breath. Its focus is to create a breath test that could make the early detection of breast cancer in women with dense breast tissue, as easy as breathing. The company product include Breathe BioMedical Breath Sampler Technology.
Company Profile
SymbolBRTH
Company NameBreathe BioMedical
CEOMr. William C. Dawes, Jr
MarketNASDAQ
Employees26
Fiscal Year Ends12-31
Company Executives
- Name
- Position
- Salary
- William C. Dawes, Jr
- Chief Executive Officer
- 987.43K
- Sandra Veenstra
- Chief Regulatory Officer
- 177.30K
- Dr. Rachel Brem, M.D.
- Chief Medical Officer and Director
- --
- Peili Miao
- Chief Financial Officer
- 31.67K
- Christopher Purves, P.Eng.
- Chief Technology Officer
- 205.65K
- Joanne Young
- Vice President, Clinical
- --
- Telfer Hanson
- Vice Chairman of the Board
- 678.60K
- Jean Nadeau
- Chairman of the Board
- 110.86K
- Romeo Goguen
- Director
- 62.75K
- Donnie Mccoy Hardison, Jr
- Independent Director
- 300.82K
- Peter G. Savas
- Independent Director
- 89.66K
- Gaetan Thomas
- Independent Director
- 62.75K
- Dr. Norman Murray Betts, PhD
- Independent Director
- 74.04K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data